The Effect of Using Distractor Cards and Thermochromic Cards on Pain, Fear, Anxiety and Procedure Time in Children Receiving Inhaler Therapy

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age3-6
SponsorMuhammed Ata Nur GEÇER

About this trial

THE EFFECT OF USİNG DİSTRACTOR CARDS AND THERMOCHROMİC CARDS ON PAİN, FEAR, ANXİETY AND PROCEDURE TİME İN CHİLDREN RECEİVİNG INHALER THERAPY.

Respiratory illnesses in children are a leading cause of childhood morbidity and mortality worldwide. Organizations such as the World Health Organization (WHO) and the Centers for Disease Control and Prevention (CDC) report that millions of children are hospitalized each year due to respiratory illnesses (He, Wang, \& Zhang, 2025). A large proportion of these illnesses are caused by viral agents, and pathogens such as Respiratory Syncytial Virus (RSV), influenza, and rhinoviruses pose serious health threats to young children (Chen, Zhang, \& Li, 2024).

This study will be one of the rare studies in pediatric nursing that examines the effectiveness of non-pharmacological interventions that can be applied during inhaler therapy in young age groups. The findings will contribute to nurses developing effective methods to reduce the negative emotions experienced by children during treatment. Furthermore, the first-ever use of thermochromic cards in this context in pediatric nursing will provide an innovative perspective on pediatric nursing practices.

H0: Thermochromic cards and distraction cards used during inhaler therapy have no effect on pain, fear, anxiety levels, or processing time.

Thermochromic cards used during inhaler therapy:

H1: reduce the child's pain. H2: reduce the child's fear. H3: reduce the child's anxiety level.

H4: shorten the child's processing time. Distraction cards used during inhaler therapy:

H5: reduce the child's pain. H6: reduce the child's fear. H7: reduce the child's anxiety level. H8: shorten the child's processing time.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

The child must be between 4-6 years old,

The child must be receiving inhaler treatment,

The child must not have received IV or IM intervention before inhaler treatment,

The child's oxygen saturation must be 95% or higher,

Disqualifiers

The child must have a cognitive or mental problem,

The child must have special needs in terms of hearing, vision and/or speech,

The child must have a life-threatening condition,

The child's oxygen saturation level must be below 95%,

Trial design

Design model

Parallel

Treatments tested in this trial

  • thermochromic card

    Other intervention

    Distraction with thermochromic card

  • distraction card

    Other intervention

    A distraction card is a visual aid used during medical procedures to reduce a child's perception of pain and fear by diverting their focus away from the procedure and towards the card.

Treatment groups

90 Participants
are divided into 3 treatment groups
Group A: thermochromic cardExperimental treatment 1 intervention
Group B: distraction cardExperimental treatment 1 intervention
Group C: clinic's routine inhaler treatment groupNo intervention 0 interventions

Trial outcomes

Primary outcomes

1

Fear level before, during, and after inhalation therapy assessed by the Child Fear Scale (ÇKÖ)

Fear level will be assessed using the Child Fear Scale (ÇKÖ), a self-report scale consisting of six facial expressions and scored from 0 to 10 in increments of two points. Higher scores indicate greater levels of fear.

Time frame
Before inhalation therapy, during the procedure, and up to 5 minutes after completion of inhalation therapy
2

Pain intensity before, during, and after inhalation therapy assessed by the Wong-Baker FACES Pain Rating Scale

Pain intensity will be measured using the Wong-Baker FACES Pain Rating Scale, which consists of six facial expressions scored from 0 to 10, where higher scores represent greater pain intensity.

Time frame
Before inhalation therapy, during the procedure, and up to 5 minutes after completion of inhalation therapy
3

Anxiety level before, during, and after inhalation therapy assessed by the Child Anxiety Scale-State (ÇAS-D)

Anxiety level will be assessed using the Child Anxiety Scale-State (ÇAS-D), a thermometer-shaped self-report scale developed for children aged 4-10 years. Higher marked levels indicate higher state anxiety.

Time frame
Before inhalation therapy, during the procedure, and up to 5 minutes after completion of inhalation therapy

Secondary outcomes

1

Duration of inhalation therapy

Procedure duration will be recorded in minutes from the start to the completion of inhalation therapy.

Time frame
During inhalation therapy

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Muhammed Ata Nur GEÇER

Lead sponsor

Istanbul University - Cerrahpasa

Sponsor institution

Bakirkoy Dr. Sadi Konuk Research and Training Hospital

Collaborator

This trial is not recruiting at the moment. You can still explore other options: